Development of novobiocin analogues that manifest anti-proliferative activity against several cancer cell lines

JA Burlison, C Avila, G Vielhauer… - The Journal of …, 2008 - ACS Publications
Recent studies have shown that the DNA gyrase inhibitor, novobiocin, binds to a previously
unrecognized ATP-binding site located at the C-terminus of Hsp90 and induces degradation …

A phase I study of the HSP90 inhibitor retaspimycin hydrochloride (IPI-504) in patients with gastrointestinal stromal tumors or soft-tissue sarcomas

AJ Wagner, R Chugh, LS Rosen, JA Morgan… - Clinical cancer …, 2013 - AACR
Purpose: Heat shock protein 90 (HSP90) is required for the proper folding, function, and
stability of various client proteins, two of which (KIT and PDGFRα) are critical in the …

In vitro Biological Characterization of a Novel, Synthetic Diaryl Pyrazole Resorcinol Class of Heat Shock Protein 90 Inhibitors

SY Sharp, K Boxall, M Rowlands, C Prodromou… - Cancer research, 2007 - AACR
The molecular chaperone heat shock protein 90 (HSP90) has emerged as an exciting
molecular target. Derivatives of the natural product geldanamycin, such as 17-allylamino-17 …

ATPase inhibitors of heat-shock protein 90, second season

YL Janin - Drug Discovery Today, 2010 - Elsevier
In the past four years, the ATP-dependent heat-shock protein 90 has remained the focus of
much interest. Phase I and phase II anticancer clinical trials with first-generation inhibitors …

The heat shock protein 90 inhibitor, AT13387, displays a long duration of action in vitro and in vivo in non‐small cell lung cancer

B Graham, J Curry, T Smyth, L Fazal, R Feltell… - Cancer …, 2012 - Wiley Online Library
A ubiquitously expressed chaperone, heat shock protein 90 (HSP 90) is of considerable
interest as an oncology target because tumor cells and oncogenic proteins are acutely …

Design, synthesis and antitumor efficacy evaluation of a series of novel β-elemene-based macrocycles

X Qi, S Jiang, Z Hui, Y Gao, Y Ye, F Lirussi… - Bioorganic & Medicinal …, 2022 - Elsevier
Abstract β-Elemene is the major constituent of the antitumor drugs elemene extract
approved in China. By incorporating macrocyclization strategy into the β-elemene skeleton …

Intracellular protein-responsive supramolecules: protein sensing and in-cell construction of inhibitor assay system

T Yoshii, K Mizusawa, Y Takaoka… - Journal of the American …, 2014 - ACS Publications
Supramolecular nanomaterials responsive to specific intracellular proteins should be greatly
promising for protein sensing and imaging, controlled drug release or dynamic regulation of …

Drug-mediated targeted disruption of multiple protein activities through functional inhibition of the Hsp90 chaperone complex

DJ Stravopodis, LH Margaritis… - Current medicinal …, 2007 - ingentaconnect.com
Hsp90 is an evolutionarily conserved and ubiquitously expressed molecular chaperone that
mainly modulates, along with a group of co-chaperones, the general platform of protein …

Ansamycin inhibitors of Hsp90: nature's prototype for anti-chaperone therapy

JR Porter, J Ge, J Lee, E Normant… - Current topics in …, 2009 - ingentaconnect.com
The ansamycin class of natural products is well known for its anti-tumor effects and has been
extensively studied by cancer researchers for nearly four decades. The first description of …

[HTML][HTML] Natural product inhibitors of Hsp90: potential leads for drug discovery

MW Amolins, BSJ Blagg - Mini reviews in medicinal chemistry, 2009 - ncbi.nlm.nih.gov
Heat shock protein 90 has emerged as a promising target for the treatment of cancer and
neurodegenerative diseases. This review summarizes recent advancements towards the …